Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video
4 other identifiers
interventional
57
1 country
1
Brief Summary
Genetic counseling and testing (GCT) provides invaluable information for women who are at-risk of hereditary breast and/or ovarian cancer (HBOC). Black women underutilize GCT compared to White women. This study will conduct a RCT to test the efficacy of a culturally-tailored theory-based video intervention aimed to address key psychosocial factors (emotions, ambivalence) to improve uptake of genetic counseling in Black women at increased risk of HBOC. Findings from this study may offer an opportunity to engage at-risk Black women regarding genetic counseling through a multi-center trial and ultimately address the disparity in genetic counseling uptake that exists between Black and White women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2020
CompletedFirst Posted
Study publicly available on registry
July 20, 2020
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2023
CompletedResults Posted
Study results publicly available
October 22, 2024
CompletedOctober 22, 2024
September 1, 2024
1.6 years
June 9, 2020
June 26, 2024
September 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of Genetic Counseling and Testing Uptake.
Our primary outcome will be for participants to receive genetic testing and counseling.Investigators will be able to see if participant has scheduled a genetic testing appointment within the VCU Health appointment system.
3 months
Secondary Outcomes (2)
Knowledge Scale - Genetic Counseling and Testing Knowledge .
Baseline was collected up to 48 hours from the start of the intervention and the follow-up was assessed within 48 hours post-intervention.
Self-efficacy Scale
Baseline was collected up to 48 hours from the start of the intervention and the follow-up was assessed within 48 hours post-intervention.
Study Arms (2)
Fact Sheet Arm
NO INTERVENTIONKomen print materials about genetic counseling and testing will be given to women.
YouTube Video Arm
ACTIVE COMPARATORParticipants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
Interventions
Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
Eligibility Criteria
You may qualify if:
- Must be at least 18 years of age
- Must be at high risk for hereditary breast or ovarian cancer
- Must identify as Black/African American
- Must be a woman
- Referred to a genetic counselor for the purpose of being high risk of carrying a hereditary breast and/or ovarian cancer mutation
- Genetic Counselors:
- Must be at least 18 years of age
- Must be qualified
- Must be approved by the PI
You may not qualify if:
- Under the age of 18
- Race other than Black/African American
- Do not gave a high risk for hereditary breast or ovarian cancer
- Genetic Counselors:
- Under 18
- Not qualified
- Not approved by the PI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Massey Cancer Center
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Vanessa Sheppard
- Organization
- Virginia Commonwealth University
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa Sheppard, PhD
Virginia Commonwealth University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2020
First Posted
July 20, 2020
Study Start
November 1, 2021
Primary Completion
June 12, 2023
Study Completion
June 12, 2023
Last Updated
October 22, 2024
Results First Posted
October 22, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.